BioCentury
ARTICLE | Financial News

GenomeDx closes series B round

October 1, 2013 12:47 AM UTC

Molecular diagnostic company GenomeDx Biosciences Inc. (Vancouver, B.C.) raised an undisclosed amount in a series B round led by new investor Merck Global Health Innovation Fund and a new undisclosed ...